Research ArticleCORONAVIRUS

Natural killer cell immunotypes related to COVID-19 disease severity

See allHide authors and affiliations

Science Immunology  21 Aug 2020:
Vol. 5, Issue 50, eabd6832
DOI: 10.1126/sciimmunol.abd6832

Article Information

vol. 5 no. 50

PubMed: 
Published By: 
History: 
  • Received July 6, 2020
  • Accepted August 19, 2020
  • .

Article Versions

Author Information

  1. Christopher Maucourant1,*,
  2. Iva Filipovic1,*,
  3. Andrea Ponzetta1,*,
  4. Soo Aleman2,3,
  5. Martin Cornillet1,
  6. Laura Hertwig1,
  7. Benedikt Strunz1,
  8. Antonio Lentini4,
  9. Björn Reinius4,
  10. Demi Brownlie1,
  11. Angelica Cuapio1,
  12. Eivind Heggernes Ask5,6,
  13. Ryan M. Hull7,
  14. Alvaro Haroun-Izquierdo1,
  15. Marie Schaffer1,
  16. Jonas Klingström1,
  17. Elin Folkesson2,8,
  18. Marcus Buggert1,
  19. Johan K. Sandberg1,
  20. Lars I. Eriksson9,10,
  21. Olav Rooyackers10,11,
  22. Hans-Gustaf Ljunggren1,
  23. Karl-Johan Malmberg1,5,6,
  24. Jakob Michaëlsson1,
  25. Nicole Marquardt1,
  26. Quirin Hammer1,
  27. Kristoffer Strålin2,3,
  28. Niklas K. Björkström1,,
  29. The Karolinska COVID-19 Study Group
  1. 1Center for Infectious Medicine, Department of Medicine Huddinge, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  2. 2Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.
  3. 3Division of Infectious Diseases and Dermatology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden.
  4. 4Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden.
  5. 5Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  6. 6K.G. Jebsen Centre for Cancer Immunotherapy, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  7. 7SciLifeLab, Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  8. 8Division of Infectious Diseases, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden.
  9. 9Department of Physiology and Pharmacology, Section for Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden.
  10. 10Function Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
  11. 11Department of Clinical Science, Intervention, and Technology (CLINTEC), Division for Anesthesiology and Intensive Care, Karolinska Institutet, Stockholm, Sweden.
  1. Corresponding author. Email: niklas.bjorkstrom{at}ki.se
  • * These authors contributed equally to this work.

  • The members of the Karolinksa COVID-19 Study Group can be found in the Acknowledgments.

Altmetric

Article usage

Article usage: August 2020 to September 2020

AbstractFullPdf
Aug 2020257209104460
Sep 2020323100722175

Stay Connected to Science Immunology

Navigate This Article